Does anyone know if chemoembolization would help for many small liver tumors. We have 50 and the largest is 1.6 cm Help..Margaret
What are the choices? What does Dr. Sato say?
As I see it you have 3 options systemic therapy- ipilimumab pd1 but neither work quick enough that number of tumours would be out of control most likely before the immune system could respond.
Percutanous or intraheptatic perfusion available in US via a doctor called James Pingbank - I think. This would perfuse the whole liver but I think you need to do it more than once and it makes you sick
SIRT - selective internal radiation theraspheres sirspheres two trade names of same product. Availble widely in US the name I know is DR Charles Nutting of Co, It would treat the whole liver and should penetrate well that size of lesion. Left overs could be mopped up with ablation.
So one of the last 2 would be the best option. Persue both simultaneously as time is short.
Got results of scan at 1 month and the largest 2 are shrinking by 3 mm or so. Don't know about the others yet. Oncologist feels like this is working for us right now. I feel it's a good option for us at present. Margaret
We had y-90 and it showed no help. We did rt. lobe in jan. and left lobe in march. I think it's in God's hands now. Margaret
If this online community is valuable to you, please consider making a tax-deductible gift to support the MRF.
Meet and talk to others about melanoma in our forums:
See also: History of the MPIP Forum
–CURE OM Forum
Raise awareness and funds to fight melanoma by participating in a Miles for Melanoma 5k walk/run this year!
Find a Miles for Melanoma event near you.
Patient Helpline: (877) 673-6460
1411 K Street, NW Suite 800
Washington, DC 20005
(800) 673-1290 Office
(202) 347-9678 Fax
The Melanoma Research Foundation (MRF) is leading the melanoma community to transform melanoma from one of the deadliest cancers to one of the most treatable through research, education and advocacy.
The Melanoma Research Foundation is a 501(c)(3) non-profit organization.